These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 33812)
1. Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by beta1- and beta2-adrenoceptors in beagle dogs: effects of procaterol, a new selective beta2-adrenoceptor agonist. Irie Y; Igawa T; Hosokawa T; Saitoh Y Eur J Pharmacol; 1979 Feb; 53(4):351-8. PubMed ID: 33812 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new beta-adrenoceptor agonist, procaterol, based on metabolic responses in rats. Saitoh Y; Irie Y; Hosokawa T; Igawa T; Hashimura F; Kohri H Biochem Pharmacol; 1978; 27(21):2531-5. PubMed ID: 31885 [No Abstract] [Full Text] [Related]
3. Comparative study of chronotropic and inotropic responses to 5-(-hydroxy-2-isopropylaminobutyl)-8-hydroxycarbostyril hydrochloride hemihydrade (procaterol), salbutamol, noradrenaline and isoprenaline in the dog heart. Chiba S Clin Exp Pharmacol Physiol; 1978; 5(6):601-6. PubMed ID: 31253 [TBL] [Abstract][Full Text] [Related]
4. Assessment of the selectivity of OPC-2009, a new beta2-adrenoceptor stimulatn, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog. Himori N; Taira N Br J Pharmacol; 1977 Sep; 61(1):9-17. PubMed ID: 21014 [TBL] [Abstract][Full Text] [Related]
5. Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects. Valet P; Taouis M; Tran MA; Montastruc P; Lafontan M; Berlan M Br J Pharmacol; 1989 May; 97(1):229-39. PubMed ID: 2566353 [TBL] [Abstract][Full Text] [Related]
6. Effects of (-)-(R)-1-(p-hydroxyphenyl)-2-[3,4-dimethoxyphenethyl)amino]ethanol (TA-064), a new cardiotonic agent, on circulating parameters of carbohydrate and lipid metabolism in the rat. Inamasu M; Totsuka T; Morita T; Takeyama S Biochem Pharmacol; 1984 Jul; 33(14):2171-7. PubMed ID: 6147139 [TBL] [Abstract][Full Text] [Related]
7. Functional beta1- and beta2-adrenoceptors in the left and right atrium of pre-hypertensive rats. Doggrell SA J Pharm Pharmacol; 2002 Oct; 54(10):1407-12. PubMed ID: 12396304 [TBL] [Abstract][Full Text] [Related]
8. Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue. Cook SJ; Small RC; Berry JL; Chiu P; Downing SJ; Foster RW Br J Pharmacol; 1993 Aug; 109(4):1140-8. PubMed ID: 8104643 [TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP accumulation in rat soleus muscle: stimulation by beta2- but not beta3-adrenoceptors. Roberts SJ; Summers RJ Eur J Pharmacol; 1998 May; 348(1):53-60. PubMed ID: 9650831 [TBL] [Abstract][Full Text] [Related]
10. Effect of beta and beta2 adrenoreceptor stimulants infused intrapancreatically on glucagon and insulin secretion. Kaneto A; Miki E; Kosaka K Endocrinology; 1975 Nov; 97(5):1166-73. PubMed ID: 241626 [TBL] [Abstract][Full Text] [Related]
11. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs. Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis. Whalen EJ; Bates JN; Johnson AK; Lewis SJ Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417 [TBL] [Abstract][Full Text] [Related]
13. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines. Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365 [TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of various beta-adrenoceptor blocking agents in rats and dogs. Traunecker W Arzneimittelforschung; 1985; 35(1A):376-82. PubMed ID: 2859032 [TBL] [Abstract][Full Text] [Related]
16. Metabolic and cardiovascular effects of isoprenaline and salbutamol in the dog. Kelly JG; Shanks RG Br J Pharmacol; 1975 Feb; 53(2):157-62. PubMed ID: 1148480 [TBL] [Abstract][Full Text] [Related]
17. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292. Smith HJ; Halliday SE; Earl DC; Stribling D J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820 [TBL] [Abstract][Full Text] [Related]
18. Effect of a selective beta 2-adrenoceptor agonist, procaterol, on tissue cyclic AMP level. Its determination after tissue fixation by microwave irradiation. Saitoh Y; Hosokawa T; Igawa T; Irie Y Biochem Pharmacol; 1979 Apr; 28(8):1319-22. PubMed ID: 87200 [No Abstract] [Full Text] [Related]
19. The functional role of beta-adrenoceptor subtypes in mediating relaxation of pig urethral smooth muscle. Yamanishi T; Chapple CR; Yasuda K; Yoshida K; Chess-Williams R J Urol; 2003 Dec; 170(6 Pt 1):2508-11. PubMed ID: 14634461 [TBL] [Abstract][Full Text] [Related]
20. The adrenergic control of hepatic glucose and FFA metabolism in rainbow trout (Oncorhynchus mykiss): increased sensitivity to adrenergic stimulation with fasting. Van Heeswijk JC; Vianen GJ; van den Thillart GE Gen Comp Endocrinol; 2006 Jan; 145(1):51-61. PubMed ID: 16102757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]